查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541709

2024-2032 年按治療類型（輸血、藥物治療、骨髓移植）、最終用戶（醫院、診斷中心等）和地區分類的鐮狀細胞疾病治療市場報告

Sickle Cell Disease Treatment Market Report by Treatment Type (Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant), End User (Hospitals, Diagnostic Centers, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球IMARC Group狀細胞疾病治療市場規模達到35億美元。

鐮狀細胞疾病 (SCD) 是一種遺傳性紅血球 (RBC) 疾病，會影響血紅蛋白，血紅蛋白是一種將氧氣輸送到全身的蛋白質。它會導致許多併發症，例如急性胸部綜合症、貧血和血管閉塞危象（VOC）。目前，醫生普遍建議進行血液和骨髓移植來治療SCD。它涉及用捐贈者提供的健康替代品替換受影響的骨髓。其他有效的治療方法，例如藥物和輸血，也正在使用，因為它們可以減輕特定症狀並延長患者的生命。

患有 SCD 的人數大幅增加是影響對能夠有效治療這種疾病的新藥物需求的重要因素之一。因此，許多國家的衛生監管機構都將重點放在新治療方法的快速批准上。例如，美國食品藥物管理局 (USFDA) 於 2019 年批准了一種新藥，用於減輕患有 SCD 的成人和兒童所經歷的疼痛。此外，政府當局正在支持研究和開發（R＆D）活動，以鼓勵研究人員和製藥公司開發新的治療方法。例如，美國國家心肺血液研究所 (NHLBI) 的研究人員正在研究基因療法，可以恢復缺失的基因或添加新的 DNA 菌株來改善細胞功能。這些創新，加上可支配收入的增加以及個人對可用醫療服務的認知不斷增強，預計將有助於市場成長。

本報告回答的關鍵問題

  • 2023年全球鐮狀細胞疾病治療市場規模有多大？ 2024-2032年全球鐮狀細胞疾病治療市場的預期成長率是多少？
  • COVID-19 對全球鐮狀細胞疾病治療市場有何影響？
  • 推動全球鐮狀細胞疾病治療市場的關鍵因素是什麼？
  • 根據治療類型，全球鐮狀細胞疾病治療市場的詳細情形如何？
  • 基於最終用戶的全球鐮狀細胞疾病治療市場的詳細情形如何？
  • 全球鐮狀細胞疾病治療市場的關鍵區域有哪些？
  • 全球鐮狀細胞疾病治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球鐮狀細胞疾病治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依治療類型

  • 輸血
    • 市場趨勢
    • 市場預測
  • 藥物治療
    • 市場趨勢
    • 市場預測
  • 骨髓移植
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 診斷中心
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AstraZeneca Plc
    • Baxter International Inc.
    • bluebird bio Inc.
    • Bristol-Myers Squibb Company
    • CRISPR Therapeutics
    • Emmaus Medical Inc.
    • Global Blood Therapeutics Inc.
    • GlycoMimetics Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sangamo Therapeutics
Product Code: SR112024A4076

The global sickle cell disease treatment market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.9 Billion by 2032, exhibiting a growth rate (CAGR) of 14% during 2024-2032.

Sickle cell disease (SCD) is a genetic red blood cell (RBC) disorder that affects hemoglobin, a protein that carries oxygen throughout the body. It leads to many complications, such as acute chest syndrome, anemia, and vaso-occlusive crisis (VOC). At present, blood and bone marrow transplant is commonly suggested by doctors for treating SCD. It involves replacing affected bone marrow with a healthy substitute received from a donor. Other effective treatments, such as medications and blood transfusions, are also being utilized as they can reduce specific symptoms and prolong the life of patients.

A considerable increase in the number of individuals suffering from SCD represents one of the significant factors influencing the demand for new medications that can treat the condition effectively. As a result, the health regulatory authorities of numerous countries are focusing on fast-track approval of new treatment methods. For instance, the United States Food and Drug Administration (USFDA) approved a new medicine in 2019 to reduce the pain experienced by adults and children with SCD. Additionally, government authorities are supporting research and development (R&D) activities to encourage researchers and pharmaceutical companies to develop novel treatments. For instance, researchers at the National Heart, Lung, and Blood Institute (NHLBI) in the US are working on genetic therapies that can restore a missing gene or add a new DNA strain to improve the functioning of cells. These innovations, along with the rising disposable incomes and the growing awareness among individuals about the available healthcare services, are anticipated to contribute to market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global sickle cell disease treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on treatment type and end user.

Breakup by Treatment Type:

Blood Transfusion

Pharmacotherapy

Bone Marrow Transplant

Breakup by End User:

Hospitals

Diagnostic Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca Plc, Baxter International Inc., bluebird bio Inc., Bristol-Myers Squibb Company, CRISPR Therapeutics, Emmaus Medical Inc., Global Blood Therapeutics Inc., GlycoMimetics Inc., Novartis AG, Pfizer Inc. and Sangamo Therapeutics.

Key Questions Answered in This Report

  • 1. What was the size of the global sickle cell disease treatment market in 2023?
  • 2. What is the expected growth rate of the global sickle cell disease treatment market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global sickle cell disease treatment market?
  • 4. What are the key factors driving the global sickle cell disease treatment market?
  • 5. What is the breakup of the global sickle cell disease treatment market based on the treatment type?
  • 6. What is the breakup of the global sickle cell disease treatment market based on the end user?
  • 7. What are the key regions in the global sickle cell disease treatment market?
  • 8. Who are the key players/companies in the global sickle cell disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sickle Cell Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Blood Transfusion
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pharmacotherapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bone Marrow Transplant
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AstraZeneca Plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Baxter International Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 bluebird bio Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bristol-Myers Squibb Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 CRISPR Therapeutics
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Emmaus Medical Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Global Blood Therapeutics Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 GlycoMimetics Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Novartis AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sangamo Therapeutics
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Sickle Cell Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Sickle Cell Disease Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Sickle Cell Disease Treatment Market: Breakup by Treatment Type (in %), 2023
  • Figure 5: Global: Sickle Cell Disease Treatment Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Sickle Cell Disease Treatment Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Sickle Cell Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Sickle Cell Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Sickle Cell Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Sickle Cell Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: North America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: North America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: United States: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: United States: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Canada: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Canada: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Asia-Pacific: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Asia-Pacific: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: China: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: China: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Japan: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Japan: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: India: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: India: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: South Korea: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: South Korea: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Australia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Australia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Indonesia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Indonesia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Europe: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Europe: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Germany: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Germany: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: France: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: France: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United Kingdom: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United Kingdom: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Italy: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Italy: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Spain: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Spain: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Russia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Russia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Latin America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Latin America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Brazil: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Brazil: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Mexico: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Mexico: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Middle East and Africa: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Middle East and Africa: Sickle Cell Disease Treatment Market: Breakup by Country (in %), 2023
  • Figure 67: Middle East and Africa: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Global: Sickle Cell Disease Treatment Industry: SWOT Analysis
  • Figure 69: Global: Sickle Cell Disease Treatment Industry: Value Chain Analysis
  • Figure 70: Global: Sickle Cell Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sickle Cell Disease Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 3: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Sickle Cell Disease Treatment Market: Competitive Structure
  • Table 6: Global: Sickle Cell Disease Treatment Market: Key Players